Viewing Study NCT00346892


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2025-12-26 @ 9:28 AM
Study NCT ID: NCT00346892
Status: COMPLETED
Last Update Posted: 2016-09-09
First Post: 2006-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module